Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SKYCellflu
- Development stage
- Phase 3
- Lead developer
- SK bioscience
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
SKYCellflu is a cell culture-derived inactivated influenza vaccine developed by SK bioscience, a subsidiary of SK Chemicals. Unlike traditional influenza vaccines produced in embryonated chicken eggs, SKYCellflu is manufactured using Madin-Darby Canine Kidney (MDCK) cell culture technology. This production method reduces the risk of egg-protein allergies and minimizes the potential for egg-adaptive mutations that can decrease vaccine effectiveness. The vaccine contains purified inactivated influenza virus surface antigens (hemagglutinin) and is available in both trivalent (NBP607) and quadrivalent (NBP607-QIV) formulations. It is indicated for the prevention of seasonal influenza in individuals aged 6 months and older. SKYCellflu was the first cell-based influenza vaccine in the world to receive WHO prequalification, highlighting its global quality and safety standards.
- Brand names
- SKYCellfluSKYCellflu Quadrivalent
- Other names
- NBP607NBP-607NBP 607NBP607-QIVNBP-607-QIVNBP 607-QIVSK cell-culture influenza vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on SKYCellflu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SKYCellflu.